Skip to main content

Cancer Immunotherapy Inches Forward

PRIMING THE IMMUNE SYSTEM:Thom GravesScientists are working on several approaches to coax the immune system into attacking cancer. Here, artificial antigen-presenting cells are used to stimulate the patient's own tumor-specific T cells.Like a modern army, the human immune system possesses an array of sophisticated cellular and molecular detection systems and weaponry. Against most pathogens these forces mount a formidable defense, but not when the disease in question involves the body's own cell

Written byAmy Adams
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00

Thom Graves

Scientists are working on several approaches to coax the immune system into attacking cancer. Here, artificial antigen-presenting cells are used to stimulate the patient's own tumor-specific T cells.

Like a modern army, the human immune system possesses an array of sophisticated cellular and molecular detection systems and weaponry. Against most pathogens these forces mount a formidable defense, but not when the disease in question involves the body's own cells. Having learned to recognize and ignore familiar proteins early in life, the immune system mostly turns a blind eye to diseases such as cancer.

As researchers look for ways to circumvent cancer's stealth capabilities, they are taking their cues from the immune system, calling their approach "cancer immunotherapy." Their cellular muse, as it were, is the dendritic cell, whose normal job is to present antigens in a way that draws the attention of cytotoxic T lymphocytes. Early clinical trials ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Placeholder image

    Amy Adams is an independent scholar who has written for The Scientist, Science, and other publications. 

    View Full Profile

Published In

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
From Pilot to Practice: Advancing Regulatory Reliance

From Pilot to Precedent: A Year of Regulatory Innovation through PRISM and What it Means for Cloud Adoption in Regulatory Submissions

DNAnexus
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Improving Western Blot Analysis of Biofluid Samples

Improving Western Blot Analysis of Biofluid Samples

Bio-Rad
Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter

Products

Sino Biological Logo

Sino Biological Advances AI-Designed Molecule Validation with 4RISE™

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation